F. Garrido

A. Concha, F. Garrido, F. Ruiz-Cabello, 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Expression of α‐tropomyosin during cardiac development in the chick embryo

J. Prados, A. Aránega, F. Garrido, 1992 .

Tracking genetically engineered bacteria: monoclonal antibodies against surface determinants of the soil bacterium Pseudomonas putida 2440

J. Ramos, I. Brettar, M. Ramos-González, 1992, Journal of bacteriology.

Biological Implications of HLA‐DR Expression in Tumours

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1995, Scandinavian journal of immunology.

HLA Class-II Expression in Human Tumors.

F. Garrido, 2019, Advances in experimental medicine and biology.

HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank

F. Garrido, F. Ruiz-Cabello, R. Méndez, 2009, Cancer Immunology, Immunotherapy.

MHC CLASS I AND II ANTIGENS ON GASTRIC CARCINOMAS AND AUTOLOGOUS MUCOSA

M. R. Oliva, A. Concha, F. Garrido, 1989, Journal of immunogenetics.

Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.

F. Garrido, M. López-Nevot, F. Ruiz-Cabello, 1987, Experimental and clinical immunogenetics.

Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.

M. R. Oliva, F. Garrido, M. López-Nevot, 1988, Experimental and clinical immunogenetics.

Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.

A. Concha, F. Garrido, F. Ruiz-Cabello, 1991, Cancer research.

MHC class I and II gene expression on human tumors.

F. Garrido, F. Ruiz-Cabello, M. A. Nevot, 1988, Advances in experimental medicine and biology.

MHC antigens and malignancy.

F. Garrido, H. Festenstein, 1986, Nature.

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

F. Esteban, A. Concha, F. Garrido, 1991, Seminars in cancer biology.

HLA class I and II expression in rhabdomyosarcomas.

A. Aránega, A. Concha, F. Garrido, 1991, Immunobiology.

HLA molecules in basal cell carcinoma of the skin.

M. R. Oliva, A. Concha, F. Garrido, 1992, Immunobiology.

MHC expression on human tumors--its relevance for local tumor growth and metastasis.

F. Garrido, F. Ruiz-Cabello, 1991, Seminars in cancer biology.

In vivo and in vitro generation of a new altered HLA phenotype in melanoma‐tumour‐cell variants expressing a single HLA‐class‐I allele

J. Zeuthen, F. Garrido, L. Real, 1998, International journal of cancer.

Tumour immunology, vaccination and escape strategies.

F. Garrido, A. Garcia-Lora, I. Algarra, 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

F. Garrido, A. Garcia-Lora, G. Garrido, 2017, Front. Pharmacol..

MHC heterogeneity and response of metastases to immunotherapy

F. Garrido, A. Garcia-Lora, I. Algarra, 2021, Cancer and Metastasis Reviews.

HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15

N. Olea, A. Concha, F. Garrido, 2018, Immunogenetics.

Recovery HLA-A2 and Beta2-microglobulin Expression in Tumor Cells Using Viral Vectors

F. Garrido, N. Aptsiauri, S. Zinchenko, 2017 .

Targeting HLA class I expression to increase tumor immunogenicity.

F. Garrido, J. Carretero, N. Aptsiauri, 2012, Tissue antigens.

Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2‐Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy

F. Garrido, G. González-Aseguinolaza, Á. Vales, 2009, Scandinavian journal of immunology.

Involvement of HLA class I molecules in the immune escape of urologic tumors.

F. Garrido, F. Vázquez-Alonso, J. Cózar, 2014, Actas urologicas espanolas.

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination

F. Garrido, L. Real, F. Ruiz-Cabello, 2007, Cancer Immunology, Immunotherapy.

Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx

F. Esteban, A. Concha, F. Garrido, 1990, Cancer.

A monoclonal antibody, GR7A4, reacting with the T10 antigen.

F. Garrido, F. Ruiz-Cabello, C. Huelin, 1987, Hybridoma.

Altered MHC class I antigens in tumors

F. Garrido, I. Algarra, A. Collado, 1997, International journal of clinical & laboratory research.

Phenotypic expression of histocompatibility antigens in human primary tumours and metastases

M. Piris, F. Esteban, M. R. Oliva, 1989, Clinical & Experimental Metastasis.

Characterization of monoclonal antibodies directed against HLA class II molecules.

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1986, Hybridoma.

HLA Class-I Expression and Cancer Immunotherapy.

F. Garrido, 2019, Advances in experimental medicine and biology.

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture

F. Garrido, F. Ruiz-Cabello, N. Aptsiauri, 2017, Vaccines.

Different mechanisms can lead to the same altered HLA class I phenotype in tumors.

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2007, Tissue antigens.

Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression

A. Concha, F. Garrido, L. Real, 2000, Cancer Immunology, Immunotherapy.

β2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors

M. R. Oliva, F. Garrido, P. Jiménez, 2000, International journal of clinical & laboratory research.

Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy

D. Schadendorf, F. Garrido, F. Ruiz-Cabello, 2006, Cancer Immunology, Immunotherapy.

Complete Loss of Hla Class I Antigen Expression on Melanoma Cells: a Result of Successive Mutational Events Publication of the International Union against Cancer

D. Schadendorf, F. Garrido, A. Sucker, 2022 .

Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy.

F. Garrido, F. Ruiz-Cabello, E. Jäger, 2001, Tissue antigens.

High frequency of altered HLA class I phenotypes in laryngeal carcinomas.

F. Garrido, T. Cabrera, M. Fernández, 2000, Human immunology.

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

F. Garrido, L. Real, P. Jiménez, 1999, International journal of cancer.

Expression of HLA G in human tumors is not a frequent event

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 1999, International journal of cancer.

HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx

F. Esteban, A. Concha, F. Garrido, 1990, Clinical & Experimental Metastasis.

Differential mRNA levels of c‐myc, c‐fos and MHC class I in several clones of a murine fibrosarcoma

H. Ljunggren, F. Garrido, I. Algarra, 1991, International journal of cancer.

DIFFERENT PATTERNS O F HLA-DR ANTIGEN EXPRESSION

A. Concha, F. Garrido, F. Ruiz-Cabello, 2006 .

DIFFERENT PATTERNS OF HLA‐DR ANTIGEN EXPRESSION IN NORMAL EPITHELIUM, HYPERPLASTIC AND NEOPLASTIC MALIGNANT LESIONS OF THE BREAST

A. Concha, F. Garrido, F. Ruiz-Cabello, 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

MHC antigens on human tumors.

E. Klein, F. Garrido, F. Ruiz-Cabello, 1991, Immunology letters.

Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.

M. R. Oliva, A. Concha, F. Garrido, 1991, Cancer research.

The Biological Implications of the Abnormal Expression of Histocompatibility Antigens on Murine and Human Tumors

F. Garrido, 1987 .

HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.

M. R. Oliva, A. Concha, F. Garrido, 1993, Tissue antigens.

The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells

F. Garrido, A. Garcia-Lora, I. Algarra, 2012, The Journal of pathology.

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

F. Garrido, M. López-Nevot, T. Cabrera, 2002, Cancer Immunology, Immunotherapy.

HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain.

F. Garrido, J. Jiménez-Alonso, M. López-Nevot, 2001, Tissue antigens.

REPRESSION OF CLASS I H‐2K,H‐2D ANTIGENS ON GR9 METHYLCHOLANTHRENE‐INDUCED TUMOUR CELL CLONES IS RELATED TO THE LEVEL OF DNA METHYLATION

F. Garrido, E. Pareja, C. Romero, 1986, Journal of immunogenetics.

Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2009, Human immunology.

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient

J. Zeuthen, F. Garrido, L. Real, 2001, Cancer Immunology, Immunotherapy.

High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity

G. Pawelec, F. Garrido, C. Roberts, 2005, Cancer Immunology, Immunotherapy.

Analysis of HLA-E expression in human tumors

D. Geraghty, F. Garrido, P. Jiménez, 2003, Immunogenetics.

Molecular strategies to define HLA haplotype loss in microdissected tumor cells.

F. Garrido, M. López-Nevot, T. Cabrera, 2000, Human immunology.

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.

F. Real, G. Berrozpe, F. Garrido, 1996, Tissue antigens.

MHC class I‐deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components

F. Garrido, A. Garcia-Lora, I. Algarra, 2003, International journal of cancer.

Differential MAGE-1 gene expression in two variants of an erythroleukemic cell line (K562).

F. Garrido, F. Ruiz-Cabello, A. Serrano, 1995, Immunobiology.

IMMUNOGENICITY OF H‐2 POSITIVE AND H‐2 NEGATIVE CLONES OF A MOUSE TUMOUR, GR9

F. Garrido, I. Algarra, M. Pérez, 1986, Journal of immunogenetics.

HLA class I expression in bladder carcinomas.

F. Garrido, T. Cabrera, J. Cózar, 2003, Tissue antigens.

Syngeneic Monoclonal Antibodies Against Chemically Induced Tumors

F. Garrido, I. Algarra, M. Pérez, 1988 .

Emergence of Foreign H‐2‐Like Cytotoxicity and Transplantation Targets on Vaccinia and Moloney Virus‐Infected Meth. A Tumour Cells

F. Garrido, H. Festenstein, A. Matossian-Rogers, 1977, Scandinavian journal of immunology.

STUDIES ON H‐2 SPECIFICITIES ON MOUSE TUMOUR CELLS BY A NEW MICRORADIOASSAY *

F. Garrido, V. Schirrmacher, H. Festenstein, 1977, Journal of immunogenetics.

CHARACTERIZATION OF THE SYNGENEIC ANTI‐TUMOUR RESPONSE AGAINST THE GR9

F. Garrido, I. Algarra, M. Pérez, 1986, Journal of immunogenetics.

Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression.

F. Garrido, L. Real, P. Jiménez, 1999, Experimental hematology.

HLA and cancer.

F. Garrido, 1996, Tissue antigens.

Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells.

M. Stanley, P. Stern, F. Garrido, 1997, Cancer research.

A monoclonal antibody GR2110 reactive with a P24 antigen present in a subgroup of acute lymphoid leukemias.

J. S. San Miguel, F. Garrido, F. Ruiz-Cabello, 1985, Hybridoma.

NK sensitivity and lung clearance of MHC‐class‐I‐deficient cells within a heterogeneous fibrosarcoma

G. Klein, H. Ljunggren, F. Garrido, 1989, International journal of cancer.

autologous metastases: demonstration ofselective losses ofHLA antigens on colorectal, gastric andlaryngeal carcinomas

F. Esteban, M. R. Oliva, F. Garrido, 1989 .

Loss of HLA Heavy Chain and β2‐Microglobulin in HLA Negative Tumours

A. Concha, F. Garrido, F. Ruiz-Cabello, 1991 .

Syngeneic tumor cells can induce alloreactive T killer cells: a biological role for transplantation antigens.

F. Garrido, V. Schirrmacher, D. Hübsch, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Methylated CpG points identified within MAGE‐1 promoter are involved in gene repression

F. Garrido, F. Ruiz-Cabello, A. Serrano, 1996, International journal of cancer.

Analysis of HLA expression in human tumor tissues

F. Garrido, M. López-Nevot, F. Ruiz-Cabello, 2002, Cancer Immunology, Immunotherapy.

14th International HLA and Immunogenetics Workshop: report on HLA expression and cancer.

F. Garrido, M. Tilanus, B. Tait, 2007, Tissue antigens.

Distribution of the CD45R antigen in the maturation of lymphoid and myeloid series: the CD45R negative phenotype is a constant finding in T CD4 positive lymphoproliferative disorders

M. Piris, F. Garrido, M. González, 1988, British journal of haematology.

Multiple mechanisms are responsible for the alteration in the expression of HLA class I antigens in melanoma

F. Garrido, F. Ruiz-Cabello, C. Traversari, 2003 .

Characterization of CD44 antigen during lymphoid ontogeny.

F. Garrido, F. Ruiz-Cabello, A. Collado, 1991, Immunobiology.

Effect of MHC class‐I transfection on local tumor growth and metastasis in an H‐2‐negative clone derived from a chemically induced fibrosarcoma

H. Ljunggren, F. Garrido, I. Algarra, 1992, International journal of cancer.

Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon.

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1996, Tissue Antigens.

Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas

A. Concha, F. Garrido, T. Cabrera, 2005, Cancer Immunology, Immunotherapy.

HETEROGENEITY OF THE EXPRESSION OF CLASS I AND II HLA ANTIGENS IN HUMAN BREAST CARCINOMA

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1986, Journal of immunogenetics.

GENERATION OF SYNGENEIC ANTI‐TUMOUR DOUBLE NEGATIVE CELLS (CD4− CD8−), WITH CYTOTOXIC ACTIVITY AGAINST CLONES OF DIFFERENT MHC CLASS I EXPRESSION.

F. Garrido, I. Algarra, M. Pérez, 1989, Journal of immunogenetics.

Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours.

D. Middleton, F. Garrido, F. Williams, 2007, Tissue antigens.

HLA and cancer: from research to clinical impact.

F. Garrido, F. Ruiz-Cabello, 1998, Immunology today.

HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15

N. Olea, A. Concha, F. Garrido, 2018, Immunogenetics.

ALPHA THALASSAEMIA IN A SOUTHERN SPANISH POPULATION

F. Garrido, M. Nieves, J. M. Pablos, 1989, British journal of haematology.

Detection of HB J-Camagüey [α141(Hc3)Arg→Gly] in Three Spanish Families

F. Garrido, M. L. Garrido, E. Abril, 1995 .

High frequency of altered HLA class I phenotypes in invasive breast carcinomas.

F. Garrido, À. Sierra, T. Cabrera, 1996, Human immunology.

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

F. Garrido, M. López-Nevot, C. Cabrera, 2004, Immunogenetics.

The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions

F. Garrido, A. Garcia-Lora, I. Algarra, 2010, Cancer Immunology, Immunotherapy.

HLA class I antigens in human tumors.

F. Garrido, M. López-Nevot, F. Ruiz-Cabello, 1995, Advances in cancer research.

Multiple mechanisms underlie HLA dysregulation in cervical cancer.

P. Stern, A. Little, F. Garrido, 2000, Tissue Antigens.

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2007, BMC Cancer.

MHC/HLA Class I Loss in Cancer Cells.

F. Garrido, 2019, Advances in experimental medicine and biology.

IMMUNOGENETIC STUDIES ON METH‐A‐VACCINIA TUMOUR CELLS IN VIVO AND IN VITRO *

F. Garrido, H. Festenstein, W. Schmidt, 1977, Journal of immunogenetics.

A RADIOASSAY FOR MACROPHAGES AND ITS APPLICATION FOR TESTING MACROPHAGE MEMBRANE ANTIGENS

F. Garrido, V. Schirrmacher, H. Festenstein, 1975 .

Rejection versus escape: the tumor MHC dilemma

Federico Garrido, F. Garrido, F. Ruiz-Cabello, 2017, Cancer Immunology, Immunotherapy.

MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.

F. Garrido, A. Garcia-Lora, I. Algarra, 2012, Carcinogenesis.

MHC class I antigens and immune surveillance in transformed cells.

F. Garrido, M. López-Nevot, F. Ruiz-Cabello, 2007, International review of cytology.

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

F. Brasseur, M. R. Oliva, T. Boon, 1998, Tissue antigens.

Tumour immunology: MHC antigens and malignancy

F. Garrido, H. Festenstein, 1986, Nature.

Further evidence for derepression of H–2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines

F. Garrido, V. Schirrmacher, H. Festenstein, 1976, Nature.

EXPRESSION OF H-2 SPECIFICITIES AND OF MuLV ENVELOPE ANTIGENS ON MURINE TUMORS

F. Garrido, V. Schirrmacher, 1977 .

ABSENCE OF FOUR H‐2d ANTIGENIC SPECIFICITIES IN AN H‐2d SARCOMA

F. Garrido, M. Pérez, M. Dolores Torres, 1979, Journal of immunogenetics.

MEMBRANE ANTIGENS RECOGNIZED BY HETEROANTISERA AGAINST MOUSE TUMOURS, TESTED IN CELL LINES OF DIFFERENT H ‐ 2 HAPLOTYPES

F. Garrido, E. García-Olivares, 1978, Journal of immunogenetics.

H–2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection

F. Garrido, V. Schirrmacher, H. Festenstein, 1976, Nature.

Expression of H-2K, H-2D and Ia region products of foreign haplotypes on mouse tumour cells [proceedings].

F. Garrido, H. Festenstein, 1976, Folia biologica.

Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma

F. Garrido, I. Algarra, J. Gaforio, 1999, International journal of clinical & laboratory research.

Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.

F. Garrido, I. Algarra, A. Collado, 1997, Journal of experimental & clinical cancer research : CR.

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape

Javier Martín, A. Concha, F. Garrido, 2017, Oncotarget.

HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy

F. Garrido, P. Anderson, F. Ruiz-Cabello, 2021, Cellular & Molecular Immunology.

Cancer immune escape: MHC expression in primary tumours versus metastases

F. Garrido, N. Aptsiauri, 2019, Immunology.

MHC antigens and tumor escape from immune surveillance.

F. Garrido, I. Algarra, Federico Garrido, 2001, Advances in cancer research.

Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas

B. Seliger, F. Garrido, I. Maleno, 2004, International journal of cancer.

Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells.

M. J. García, J. O'connor, M. R. Oliva, 2004, Cancer letters.

Studies on CD11a and CD18 molecules with two new monoclonal antibodies: differential myelomonocytic antigen expression of PMA treated HL60 and U937 cell lines.

F. Garrido, F. Ruiz-Cabello, M. Patarroyo, 1989, Hybridoma.

Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.

F. Garrido, A. Garcia-Lora, Irene Romero, 2014, Cancer research.

T lymphocytes restrain spontaneous metastases in permanent dormancy.

F. Garrido, A. Garcia-Lora, I. Algarra, 2014, Cancer research.

Microsatellite instability in cervical intraepithelial neoplasia.

A. Concha, F. Garrido, L. Real, 1998, Journal of experimental & clinical cancer research : CR.

The urgent need to recover MHC class I in cancers for effective immunotherapy

F. Garrido, N. Aptsiauri, T. van Hall, 2016, Current opinion in immunology.

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape

Federico Garrido, F. Garrido, F. Ruiz-Cabello, 2004, Cancer Immunology, Immunotherapy.

K‐ras mutations (codon 12) are not involved in down‐regulation of mhc class‐i genes in colon carcinomas

M. R. Oliva, F. Garrido, F. Ruiz-Cabello, 1990, International journal of cancer.

Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report

F. Garrido, F. Ruiz-Cabello, N. Aptsiauri, 2008, Journal of medical case reports.

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.

P. Stern, M. López-Botet, F. Garrido, 1997, Immunology today.

Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes

A. Concha, F. Garrido, F. Ruiz-Cabello, 2021, International journal of molecular sciences.

CRC: A Darwinian model of cellular immunoselection

A. Concha, F. Garrido, F. Ruiz-Cabello, 2022, Foundations of Colorectal Cancer.

A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer

F. Garrido, J. Flores-Martín, J. Cózar-Olmo, 2019, Annals of Surgical Oncology.

Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

F. Garrido, M. López-Nevot, N. Aptsiauri, 2011, Immunogenetics.

Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset

F. Garrido, P. Anderson, P. Jiménez, 2020, Frontiers in Immunology.

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.

J. Blay, N. Halama, D. Jäger, 2013, Cancer research.

Clinical Studies Immune In fi ltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

Ager, J. Blay, N. Halama, 2013 .

Studies Immune In fi ltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

J. Blay, N. Halama, P. Opolon, 2013 .

Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.

H. Rammensee, A. Concha, F. Garrido, 2010, Tissue antigens.

A study of GRM1 monoclonal antibody that reacts with natural killer cells and granulocytes.

F. Garrido, F. Ruiz-Cabello, M. A. López Nevot, 1987, Natural immunity and cell growth regulation.

Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms

F. Garrido, L. E. Fernández, A. Garcia-Lora, 2014, Oncogene.

Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer

F. Garrido, F. Ruiz-Cabello, J. Cózar, 2008, BMC Cancer.

Analysis of HLA–ABC locus-specific transcription in normal tissues

F. Garrido, F. Ruiz-Cabello, R. Méndez, 2010, Immunogenetics.

Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients

F. Garrido, P. Anderson, M. López-Nevot, 2021, Journal of Microbiology, Immunology and Infection.

Chapter 7 IFN Inducibility of Major Histocompatibility Antigens in Tumors

B. Seliger, F. Garrido, F. Ruiz-Cabello, 2008, Advances in Cancer Research.

Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genes

Federico Garrido, Francesco M Marincola, Ena Wang, 2012, International journal of cancer.

Senile cataracts and the HLA system.

F. Garrido, E. Pareja, M. J. Bolaños, 1982, British Journal of Ophthalmology.

Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.

F. Garrido, F. Ruiz-Cabello, J. Cózar, 2012, Human immunology.

Characterization of a gastric tumor cell line defective in MHC class I inducibility by both α- and γ-interferon

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1996 .

The absence of HLA class I expression in non‐small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration

F. Garrido, Clara Bayarri, F. Ruiz-Cabello, 2017, International journal of cancer.

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype

F. Garrido, N. Aptsiauri, A. Garcia-Lora, 2016, International journal of cancer.

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

F. Garrido, S. Ward, J. Flores-Martín, 2015, Cancer Immunology, Immunotherapy.

Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity

A. Concha, F. Garrido, F. Ruiz-Cabello, 2011, Cancer Immunology, Immunotherapy.

“Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy

F. Garrido, N. Aptsiauri, T. Cabrera, 2010, International journal of cancer.

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

F. Garrido, L. Real, N. Aptsiauri, 2008, Cancer Immunology, Immunotherapy.

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines

G. Pawelec, F. Garrido, P. Jiménez, 2008, Cancer Immunology, Immunotherapy.

Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response

F. Garrido, M. López-Nevot, C. Cabrera, 2007, International journal of cancer.

International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain

G. Pawelec, F. Garrido, N. Aptsiauri, 2007, Cancer Immunology, Immunotherapy.

Patterns of constitutive and IFN-γ inducible expression of HLA class II molecules in human melanoma cell lines

D. Schadendorf, G. Pawelec, F. Garrido, 2007, Immunogenetics.

Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.

F. Garrido, F. Ruiz-Cabello, N. Aptsiauri, 2006, Tissue antigens.

LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas

F. Garrido, M. López-Nevot, N. Aptsiauri, 2006, Immunogenetics.

Oxidative stress induces the expression of the major histocompatibility complex in murine tumor cells

M. R. Oliva, F. Garrido, G. Sáez, 2001, Free radical research.

EXPRESSION OF HLA CLASS I ANTIGENS AND RESTORATION OF ANTIGEN-SPECIFIC CTL RESPONSE IN MELANOMA CELLS FOLLOWING 5-AZA-2 9-DEOXYCYTIDINE TREATMENT

F. Garrido, F. Ruiz-Cabello, R. Méndez, 2001 .

Looking for HLA-G expression in human tumours.

F. Garrido, L. Real, F. Ruiz-Cabello, 1999, Journal of reproductive immunology.

A new beta 2 microglobulin mutation found in a melanoma tumor cell line.

M. R. Oliva, F. Garrido, M. Fernández, 1999, Tissue antigens.

Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line

F. Garrido, L. Real, P. Jiménez, 1998, Cancer Immunology, Immunotherapy.

DIFFERENTIAL EXPRESSION OF HLA CLASS I AND II ANTIGENS IN PRIMARY AND METASTATIC MELANOMAS

F. Garrido, F. Ruiz-Cabello, E. Pareja, 1986, Journal of immunogenetics.

Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3–5, 2011

F. Garrido, N. Aptsiauri, T. Cabrera, 2012, Cancer Immunology, Immunotherapy.

Bacillus Calmette‐Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I‐deficient tumor cells

F. Garrido, N. Aptsiauri, T. Cabrera, 2011, International journal of cancer.

Molecular analysis of MHC‐class‐I alterations in human tumor cell lines

A. Concha, F. Garrido, F. Ruiz-Cabello, 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement.

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy

F. Garrido, A. Garcia-Lora, I. Algarra, 2018, Front. Immunol..

A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.

A. Concha, F. Garrido, F. Ruiz-Cabello, 2009, Human immunology.

Class II HLA antigen expression in familial polyposis coli is related to the degree of dysplasia.

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1990, Immunobiology.

HLA and cancer: 12th International Histocompatibility Workshop study

F. Marincola, W. Bodmer, G. Ferrara, 1997 .

Production of monoclonal antibodies to metacyclic trypomastigotes of Trypanosoma cruzi.

F. Garrido, F. Ruiz-Cabello, M. Campos, 1986, Hybridoma.

HLA antigens in brucellosis.

F. Garrido, E. Pareja, D. Salvatierra, 1985, Experimental and clinical immunogenetics.

Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.

Javier Martín, E. Sánchez, F. Garrido, 2010, Human immunology.

Can the HLA phenotype be used as a prognostic factor in breast carcinomas?

A. Concha, F. Garrido, F. Ruiz-Cabello, 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Different CD45 and CD45R epitopes involved in T cell proliferation and NK cytotoxicity.

F. Garrido, F. Ruiz-Cabello, C. Huelin, 1989, Hybridoma.

Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors.

F. Garrido, I. Algarra, A. Collado, 1999, Journal of experimental & clinical cancer research : CR.

EXPRESSION OF FOREIGN H‐2‐LIKE ANTIGENS BY A CHEMICALLY‐INDUCED MURINE TUMOUR (MCG4)

F. Garrido, V. Schirrmacher, M. Pérez, 1980, Journal of immunogenetics.

A syngeneic anti tumor serum recognizing a complex H-2 alloantigen.

F. Garrido, V. Schirrmacher, E. García-Olivares, 1979, Immunobiology.

Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor.

F. Garrido, I. Algarra, M. Pérez, 1986, Experimental and clinical immunogenetics.

‘Hard’ and ‘soft’ loss of MHC class I expression in cancer cells

F. Garrido, N. Aptsiauri, A. Garcia-Lora, 2014 .

A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells

P. Stern, F. Garrido, P. Jiménez, 2000, Immunogenetics.

Unexpected H-2 antigen expression by mouse tumor cells, a cautionary note

P. Altevogt, F. Garrido, V. Schirrmacher, 2004, Immunogenetics.

Criteria to define HLA haplotype loss in human solid tumors.

F. Garrido, M. Tilanus, M. López-Nevot, 2000, Tissue antigens.

Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas.

F. Esteban, A. Concha, F. Garrido, 1997, Cancer detection and prevention.

A novel preclinical murine model of immune-mediated metastatic dormancy

F. Garrido, A. Garcia-Lora, Irene Romero, 2014, Oncoimmunology.

A new extract of the plant calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation

F. Garrido, A. Garcia-Lora, I. Algarra, 2006, BMC Cancer.

Antigen Society #21 Report DR1, DRw10)

R. Winchester, R. Fauchet, G. Dunston, 1989 .

In vivo generation, enhancement and recruitment of host cellular immune responses against tumor: influence of MHC antigen expression on clones of tumor cell variants.

F. Garrido, E. Fernandez-cruz, J. Zabay, 1987, Progress in clinical and biological research.

Complete loss of HLA class I antigen expression on melanoma cells: A result of successive mutational events

D. Schadendorf, F. Garrido, A. Sucker, 2003, International journal of cancer.

Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma

S. Aamdal, F. Garrido, G. González-Aseguinolaza, 2014, International journal of cancer.

Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2009, Human immunology.

Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL.

U. Koszinowski, F. Garrido, V. Schirrmacher, 1980, Transplantation proceedings.

Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines.

F. Garrido, V. Schirrmacher, H. Festenstein, 1976, Nature.

Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.

D. Schadendorf, G. Pawelec, F. Garrido, 2007, Immunogenetics.